The resources on this page are designed to support community pharmacists using PharmOutcomes with hospital medication referrals.

Please note that due to hospital systems and agreements in your area, the videos and guidance on this page may show a variation from how information is transferred and collected for your service. Resources will be updated as the project launches across your area. Please contact your local LPC for further information.

Learn more through the film resources below

Click to watch the training films on using the PharmOutcomes website interface to make a hospital referral to community.

Community Pharmacy

This video is a representation of the community pharmacists view on PharmOutcomes. Your view may differ slightly dependent on which trust the referral has come from. For exact details please speak to your local LPC lead.

Hospital Pharmacy

The videos below are a representation of the Trust view. These may differ from your Trusts view. For further details speak to your local Trust lead for exact details.








The EMOP programme is intended to improve communication between the hospital pharmacy team and community pharmacy colleagues. The main focus will primarily be on patients most at risk from medication changes following hospital admission and discharge. EMOP will improve patient pathways and become more integrated across different sectors of care (current practice is inconsistent, relying on the use of telephone and fax to inform community pharmacy without any record of their continuity of care).

Having obtained consent from the patient, the EMOP programme, through the use of PharmOutcomes, allows the hospital pharmacy team to electronically send patient TTO (medication discharge) details directly to their community pharmacist so that they can get advice about any of the changes to their medicines. PharmOutcomes will alert community pharmacists that their patients are being discharged and may need a suitable follow-up. This avoids any prescription or medication currently in the system to be intercepted and interrogated before any supply is made to the patients.

The EMOP programme will ensure patients are supported to get the most from their medicines and remain in a better state of health through formal contact with their community pharmacist. The aim of the pathway is to result in fewer hospital re-admissions or emergency department attendances as a result of medication errors in particular if their old medicines were a contributory factor to their admission to the hospital.

EMOP offers community pharmacists an opportunity to use their clinical skills and to be an integral part of the patient pathway. It also facilitates a greater degree of professional relationship with their patients and allows community pharmacies to plan their workload better when patients are discharged from hospital.

EMOP allows the hospital team to communicate in a safe and secure way with their community pharmacist colleagues around any medication issues, continuity of supply and if any follow ups need to be flagged up. The fully integrated model will free up the hospital team from attempting to make a telephone and fax communication in the knowledge that their communication is securely delivered and acknowledged by their community pharmacy colleagues.

EMOP supports GPs by reducing the need for unplanned hospital re-admissions due to medication errors for patients at risk of post-discharge medicines adherence issues. Community pharmacy will be in a position to interrogate new prescriptions they have received against the discharge information and clarify any discrepancies. GPs will also benefit by knowing a patient has been through a medicines adherence programme and provides them with the added assurance that their patients are taking their medicines correctly and limiting medicine waste.

Due to the nature of admissions, patients are less likely to be able to retain all the information provided to them prior to discharge. Their medicines-related problems after discharge from hospital can be addressed by more systematic involvement of their community pharmacists supporting the discharge process.

Hospital pharmacy teams, as part of their patient medication reconciliation process during admission could decide to identify the cohort of patients based on the likely changes to their medication. Additionally, all patients included in the EMOP pathway are required to give their consent to have their information about their admission and discharge communicated to their regular community pharmacy.

This will vary from hospital to hospital and their pharmacy communication policy and the trust pharmacy team may decide to send all verified discharges or focus mainly on those patients who could benefit most from their community pharmacist having the most up to date information about their new medicines or dose changes following discharge (e.g. changes to blister packs or care home residents’ medicines).

EMOP is designed to be a fully integrated solution with hospital systems. PharmOutcomes automatically picks the generated discharge information at the point of discharge from the hospital’s message handler without any additional workload from the hospital team through a secure N3 link that meets stringent IG standards.

None, as the EMOP discharge information sent to community pharmacies is already included as part of the existing information received at GP practices following patient discharge.

The information being sent to community pharmacies via PharmOutcomes is there to assist pharmacies to better plan their workloads and to assist patients by being “in the loop” with regards to admission and discharge information. Pharmacists can, for the first time, review patient discharge information and work with their local GP practices to ensure that patients receive the appropriate medication support. There are already advanced pharmacy services in the national contract to support this type of review, such as, NMS (new medicines service) and MUR (medicine use reviews). If admission notifications become available in the pathway for community pharmacies they will be also able to put on hold any dispensing activities for patients and avoid unnecessary workload, for example, production of MDS (blister packs).

PharmOutcomes uses secure N3 connection meeting strongest IG standards. All pharmacies included in the pathway will also meet the minimum IG standards as prescribed by NHS England through their contractual framework. Additionally, there is full encryption of the patient’s data in transit and can only be accessed by the community pharmacy in the pathway through a very secure access gate. The processes ensure secure and audit-able retrieval or rejection of the referral by the community pharmacy.

Community pharmacists need to be aware that some hospitals will be unable to provide a list of all stopped medicines, but local guidance will be available through the Local Pharmaceutical Committee. Any information on stopped medicines can be sent out in two ways:

1) If it is currently captured in one of the hospital systems e.g. PAS or dispensing system, then it may be captured by PharmOutcomes.

2) If this information is not currently captured or can’t be captured from existing systems then it may be added via a free text field, if there is one available on the hospital systems. 

3) If a site is not able to capture stopped medication, an alert box can be added to notify the community pharmacist that the drug information is a complete list of medications on hospital discharge, and does not include any medications stopped during the patient’s hospital stay.

© Eastern AHSN